Vaccine

TRANSVAC2 offers technical services at all stages of the Vaccine R&D pipeline to support the development of prophylactic and therapeutic vaccines for human and veterinary use.

Stay tuned for the
next open TNA call

Vaccine

TRANSVAC2 offers technical services at all stages of the Vaccine R&D pipeline to support the development of prophylactic and therapeutic vaccines for human and veterinary use.

Open TNA Call
Submit your application
until January 15th

logoTransvac_white.png

IMPROVING AND ACCELERATING VACCINE DEVELOPMENT IN EUROPE

Currently there is no open call for training modules
Application Form becomes available at the start of each open TNA call

Services at all stages

of the Vaccine R&D Pipeline

vaccine wo background.png

 OPEN CALL for SERVICES 

Submit your application for Vaccine Development Services

Services at all stages

of the Vaccine R&D Pipeline

vaccine wo background.png

 OPEN CALL for SERVICES 

Submit your application for Vaccine Development Services

TRANSVAC2 TNA CALL FOR PROPOSALS

With the pandemic still ongoing, TRANSVAC2 is renewing its commitment to supporting academic and commercial vaccine developers through a new call for proposals dedicated to SARS-CoV-2 / COVID-19, with a special emphasis on variants of concern. Other project proposals will also be considered.

You may apply for free-of-charge TNA vaccine development services to advance your research in one of the following main areas:

 

Technology

Antigen screening, optimization, expression, and production

Adjuvant formulation and characterization (incl. liposomal, mucosal, and parenteral adjuvants)

Analytical services offer diverse structural and cellular assays (Now including Luminex potency assay!)

GLP/GMP vaccine production using bacterial, yeast, plant, insect, and mammalian platforms

 

Immunocorrelates/ systems biology

Includes sequencing, cytometry and various -omics services

Statistical analysis and mathematical modelling

 

Animal models

Services offer a wide range of species and validated disease models, from rodents to NHPs

 

Clinical trial and regulatory support services

We highly encourage all applicants to request regulatory support alongside scientific technical services, as early assessment of regulatory requirements may prevent unnecessary project delays, reduce costs and ensure adherence to legal requirements.

 

Service availability is dependent on budgetary, and timeline constrains and thus subject to change at later stages of the application process. Applicants should contact service providers before submission.

z

DEADLINE

This call for proposals will remain open until May 31st, 2022. Your proposal will be evaluated, selected and implemented according to the selection process.

 

APPLICATION

Applicants can be affiliated to an organization (public or private) located in the EU, an associated country or any other country. For more information about TRANSVAC2 TNA Programme, including the conditions for access & eligibility, please refer to Apply now.

To apply, please make sure that you use the latest TNA Application Form linked and carefully read the form and help text.

Please note that an organization can submit several applications led by different Users.

For any further question, please contact TRANSVAC2 Coordinating team (transvacinfo@euvaccine.eu).